Neurogenetics Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginitio Hospital, Athens, Greece.
Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Québec, Canada.
Clin Genet. 2024 Apr;105(4):446-452. doi: 10.1111/cge.14482. Epub 2024 Jan 14.
A pathogenic GAA repeat expansion in the first intron of the fibroblast growth factor 14 gene (FGF14) has been recently identified as the cause of spinocerebellar ataxia 27B (SCA27B). We herein screened 160 Greek index cases with late-onset cerebellar ataxia (LOCA) for FGF14 repeat expansions using a combination of long-range PCR and bidirectional repeat-primed PCRs. We identified 19 index cases (12%) carrying a pathogenic FGF14 GAA expansion, a diagnostic yield higher than that of previously screened repeat-expansion ataxias in Greek LOCA patients. The age at onset of SCA27B patients was 60.5 ± 12.3 years (range, 34-80). Episodic onset (37%), downbeat nystagmus (32%) and vertigo (26%) were significantly more frequent in FGF14 expansion-positive cases compared to expansion-negative cases. Beyond typical cerebellar signs, SCA27B patients often displayed hyperreflexia (47%) and reduced vibration sense in the lower extremities (42%). The frequency and phenotypic profile of SCA27B in Greek patients was similar to most other previously studied populations. We conclude that FGF14 GAA repeat expansions are the commonest known genetic cause of LOCA in the Greek population and recommend prioritizing testing for FGF14 expansions in the diagnostic algorithm of patients with LOCA.
最近,在成纤维细胞生长因子 14 基因(FGF14)的第一个内含子中发现了一种致病性 GAA 重复扩展,这是脊髓小脑性共济失调 27B(SCA27B)的病因。我们在此使用长距离 PCR 和双向重复引物 PCR 的组合,对 160 名希腊首发晚发性小脑共济失调(LOCA)索引病例进行了 FGF14 重复扩展筛查。我们鉴定出 19 名携带致病性 FGF14 GAA 扩展的索引病例(12%),这一诊断率高于之前在希腊 LOCA 患者中筛查的重复扩展共济失调。SCA27B 患者的发病年龄为 60.5±12.3 岁(范围 34-80 岁)。与扩展阴性病例相比,SCA27B 患者的发作性起病(37%)、下跳性眼球震颤(32%)和眩晕(26%)更为常见。除了典型的小脑体征外,SCA27B 患者还常表现为反射亢进(47%)和下肢振动觉减退(42%)。希腊患者的 SCA27B 频率和表型谱与其他大多数先前研究的人群相似。我们得出结论,FGF14 GAA 重复扩展是希腊人群中 LOCA 最常见的已知遗传原因,并建议在 LOCA 患者的诊断算法中优先进行 FGF14 扩展检测。